149 related articles for article (PubMed ID: 35870987)
21. Clinical and genomic characterization of Chinese patients with functional high-risk multiple myeloma: A real-world validation study.
Wang YT; Chu B; Zhou TG; Lu MQ; Shi L; Gao S; Fang LJ; Xiang QQ; Zhao X; Wang MZ; Sun K; Bao L
Front Oncol; 2023; 13():1110693. PubMed ID: 36969050
[TBL] [Abstract][Full Text] [Related]
22. Pleural effusion-based nomogram to predict outcomes in unselected patients with multiple myeloma: a large single center experience.
Hou ZL; Kang Y; Yang GZ; Wang Z; Wang F; Yu YX; Chen WM; Shi HZ
Ann Hematol; 2021 Jul; 100(7):1789-1801. PubMed ID: 33715037
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of genetic alterations and methylation classes in meningioma.
Berghoff AS; Hielscher T; Ricken G; Furtner J; Schrimpf D; Widhalm G; Rajky U; Marosi C; Hainfellner JA; von Deimling A; Sahm F; Preusser M
Brain Pathol; 2022 Mar; 32(2):e12970. PubMed ID: 35213082
[TBL] [Abstract][Full Text] [Related]
24. Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma.
He J; Yue X; He D; Zhao Y; Yang Y; Zheng G; Zhang E; Han X; Wu W; Yang L; Chen J; Cai Z
Front Oncol; 2021; 11():668099. PubMed ID: 34307138
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic significance of different IDH mutations and accompanying gene mutations in patients with acute myeloid leukemia].
Wu RY; Xie XS; Wei Y; Jang ZX; Chen DD; Sun H; Wan DM; Liu YF; Sun L
Zhonghua Xue Ye Xue Za Zhi; 2021 Jan; 42(1):39-44. PubMed ID: 33677867
[No Abstract] [Full Text] [Related]
26. Low Barthel index score is a poor prognostic factor for newly diagnosed multiple myeloma patients.
Geng C; Yang G; Zhou H; Wang H; Li Y; Leng Y; Zhang Z; Jian Y; Chen W
Clin Exp Med; 2023 Oct; 23(6):2593-2600. PubMed ID: 36703087
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics and prognostic values of 1p32.3 deletion detected through fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma: a single-center study in China.
Wang H; Meng H; Wang J; Lou Y; Zhou Y; Lin P; Li F; Liu L; Xu H; Yang M; Jin J
Front Med; 2020 Jun; 14(3):327-334. PubMed ID: 31784918
[TBL] [Abstract][Full Text] [Related]
28. Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients.
Janusz K; Izquierdo MM; Cadenas FL; Ramos F; Sánchez JMH; Lumbreras E; Robledo C; Del Real JS; Caballero JC; Collado R; Bernal T; Pedro C; Insunza A; de Paz R; Xicoy B; Salido E; García JS; Mínguez SS; García CM; Muñoz AMS; Barba MS; Rivas JMH; Abáigar M; Campelo MD
Ann Hematol; 2021 Aug; 100(8):1995-2004. PubMed ID: 33409621
[TBL] [Abstract][Full Text] [Related]
29. EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible Mechanisms.
Goldsmith SR; Fiala MA; O'Neal J; Souroullas GP; Toama W; Vij R; Schroeder MA
Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):744-750. PubMed ID: 31551170
[TBL] [Abstract][Full Text] [Related]
30. MRI-Based Bone Marrow Radiomics Nomogram for Prediction of Overall Survival in Patients With Multiple Myeloma.
Li Y; Liu Y; Yin P; Hao C; Sun C; Chen L; Wang S; Hong N
Front Oncol; 2021; 11():709813. PubMed ID: 34926240
[TBL] [Abstract][Full Text] [Related]
31. High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma.
Gu Y; Yuan YH; Xu J; Shi QL; Qu XY; Guo R; Bai H; Xu JD; Li JY; Chen LJ
Oncotarget; 2017 Jul; 8(29):48350-48361. PubMed ID: 28418851
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.
Danziger SA; McConnell M; Gockley J; Young MH; Rosenthal A; Schmitz F; Reiss DJ; Farmer P; Alapat DV; Singh A; Ashby C; Bauer M; Ren Y; Smith K; Couto SS; van Rhee F; Davies F; Zangari M; Petty N; Orlowski RZ; Dhodapkar MV; Copeland WB; Fox B; Hoering A; Fitch A; Newhall K; Barlogie B; Trotter MWB; Hershberg RM; Walker BA; Dervan AP; Ratushny AV; Morgan GJ
PLoS Med; 2020 Nov; 17(11):e1003323. PubMed ID: 33147277
[TBL] [Abstract][Full Text] [Related]
33. [Adverse effects of double-hit combining ISS-Ⅲ stage and 1q gain or del (17p) on prognosis of patients with newly diagnosed multiple myeloma].
Liu XL; Yang YP; Bai J; Yue TT; Yang PY; Zhang Y; Fan HQ; Li W; Jin FY
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):912-917. PubMed ID: 31856439
[No Abstract] [Full Text] [Related]
34. [Prognostic factors in newly diagnosed multiple myeloma patients with 1q21 amplification/gain treated with bortezomib-based regimens followed by autologous hematopoietic stem cell transplantation].
Huang WY; Zou DH; Liu W; An G; Xu Y; Sui WW; Deng SH; Li CW; Liu H; Li J; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):496-500. PubMed ID: 30032568
[No Abstract] [Full Text] [Related]
35. Multiple Myeloma Minimal Residual Disease Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone Marrow.
Langerhorst P; Noori S; Zajec M; De Rijke YB; Gloerich J; van Gool AJ; Caillon H; Joosten I; Luider TM; Corre J; VanDuijn MM; Dejoie T; Jacobs JFM
Clin Chem; 2021 Nov; 67(12):1689-1698. PubMed ID: 34643690
[TBL] [Abstract][Full Text] [Related]
36. Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models.
Cheng Q; Cai L; Zhang Y; Chen L; Hu Y; Sun C
Front Oncol; 2021; 11():639528. PubMed ID: 33747963
[No Abstract] [Full Text] [Related]
37. Correlation between Clinical Factors and Prognosis in Newly Diagnosed Multiple Myeloma.
Zhao XQ; Zhao SY; Chen WX; Liu XW; Yan HX; Lou YJ
J Coll Physicians Surg Pak; 2020 Jun; 30(6):601-605. PubMed ID: 32703344
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of
Han S; Woo S; Kim YI; Yoon DH; Ryu JS
Eur Radiol; 2021 Jan; 31(1):152-162. PubMed ID: 32809165
[TBL] [Abstract][Full Text] [Related]
39. The paradoxical prognostic role of 1q21 Gain/Amplification in multiple myeloma: every coin has two sides.
Xu J; Xu T; Yang Y; Wang W; Li J; Ren Y; Gu S; Chen C; Wei Z; Zhuang J; Wang Z; Ji L; Cheng L; Wang W; Cheng Z; Ke Y; Yuan L; Liu P
Leuk Lymphoma; 2020 Oct; 61(10):2351-2364. PubMed ID: 32519901
[TBL] [Abstract][Full Text] [Related]
40. Prognostic prediction of glioblastoma by quantitative assessment of the methylation status of the entire MGMT promoter region.
Kanemoto M; Shirahata M; Nakauma A; Nakanishi K; Taniguchi K; Kukita Y; Arakawa Y; Miyamoto S; Kato K
BMC Cancer; 2014 Aug; 14():641. PubMed ID: 25175833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
